FDA's Evolving Position On Next-Gen Sequencing – And Using Data It Produces
Executive Summary
Rapid advances in genetic screening technology have prompted an FDA effort to overhaul its approach to diagnostic regulation and to consider ways to make genomic data available to the health system.